Abstract CT006: Phase Ib Expansion Trial of the Safety and Efficacy of the Oral Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response (DDR) Defects
Cancer Research(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined